Literature DB >> 11043393

Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours.

I Ak1, M P Stokkel, E K Pauwels.   

Abstract

The tumoral uptake of 2-[18F]fluoro-2-deoxy-D-glucose (18FdGlc) is based upon enhanced glycolysis. Positron-emission tomography (PET) using 18FdGlc provides the physiological and metabolic information. 18FdGlc PET has been used successfully for assessing primary tumours and metastases, prognosis, and planning and for monitoring tumour therapy as well as for early detection of recurrent tumour growth. This review summarises the uptake mechanism of 18FdGlc in benign and malignant lesions, its relation to histopathology, and its clinical value for detecting and staging primary tumours.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11043393     DOI： 10.1007/pl00008466

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


  18 in total

1.  Is 11C-choline the most appropriate tracer for prostate cancer? For.

Authors:  Ferruccio Fazio; Maria Picchio; Cristina Messa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-02       Impact factor: 9.236

2.  Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer.

Authors:  G Mangili; M Picchio; S Sironi; R Viganò; E Rabaiotti; D Bornaghi; V Bettinardi; C Crivellaro; C Messa; F Fazio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-20       Impact factor: 9.236

3.  ¹⁸F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis.

Authors:  Rachele Bonfiglioli; Cristina Nanni; Joshua James Morigi; Maddalena Graziosi; Filippo Trapani; Michele Bartoletti; Fabio Tumietto; Valentina Ambrosini; Alice Ferretti; Domenico Rubello; Claudio Rapezzi; Pier Luigi Viale; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-08       Impact factor: 9.236

4.  Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma.

Authors:  Jun Sato; Yoshimasa Kitagawa; Yutaka Yamazaki; Hironobu Hata; Takuya Asaka; Masaaki Miyakoshi; Shozo Okamoto; Tohru Shiga; Masanobu Shindoh; Yuji Kuge; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-28       Impact factor: 9.236

Review 5.  Glycolytic genes in cancer cells are more than glucose metabolic regulators.

Authors:  Zhe-Yu Hu; Lanbo Xiao; Ann M Bode; Zigang Dong; Ya Cao
Journal:  J Mol Med (Berl)       Date:  2014-06-08       Impact factor: 4.599

6.  Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study.

Authors:  Mei Tian; Hong Zhang; Yoshiki Nakasone; Kenji Mogi; Keigo Endo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-10       Impact factor: 9.236

7.  Role of 18F-FDG PET in the management of gestational trophoblastic neoplasia.

Authors:  P Mapelli; G Mangili; M Picchio; C Gentile; E Rabaiotti; V Giorgione; E G Spinapolice; L Gianolli; C Messa; M Candiani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-12       Impact factor: 9.236

8.  Optimisation of the OS-EM algorithm and comparison with FBP for image reconstruction on a dual-head camera: a phantom and a clinical 18F-FDG study.

Authors:  Fabrice Gutman; Isabelle Gardin; Nicolas Delahaye; Hervé Rakotonirina; Anne Hitzel; Alain Manrique; Dominique Le Guludec; Pierre Véra
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-09-23       Impact factor: 9.236

9.  Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors.

Authors:  B Böhm; M Voth; J Geoghegan; H Hellfritzsch; A Petrovich; J Scheele; D Gottschild
Journal:  J Cancer Res Clin Oncol       Date:  2004-02-06       Impact factor: 4.553

10.  Kinetics of hyperpolarized 13C1-pyruvate transport and metabolism in living human breast cancer cells.

Authors:  Talia Harris; Galit Eliyahu; Lucio Frydman; Hadassa Degani
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-13       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.